Intended for healthcare professionals

Latest dermatology news


Global atopic dermatitis awareness campaign launched

Atopic dermatitis is a chronic, inflammatory skin disease characterised by intense itch and eczematous lesions

15 Dec 2022

Promising results from phase 2 skin cancer trial

The study demonstrated a 63.3% combined pathologic response rate, with 50.6% of patients achieving the primary endpoint of complete pathologic response

15 Dec 2022

Dermavant’s Vtama shows promise in paediatric atopic dermatitis trial

There was a low incidence of adverse events and, even when applied to areas of sensitive skin, Vtama was well tolerated

12 Dec 2022

Almirall’s lebrikizumab approved by EMA for atopic dermatitis

The decision is based on three pivotal phase 3 studies: ADvocate 1, ADvocate 2 and ADhere

12 Dec 2022

Research shows impact of immune checkpoint blockers in skin cancer

The research was published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society

12 Dec 2022

Novartis and Kaiku Health expand digital health monitoring partnership

The collaboration hopes to generate novel insights on patient outcomes in a real-world setting

12 Dec 2022

Bristol Myers Squibb’s Opdivo shows promise as adjuvant melanoma treatment

The PD-1 inhibitor demonstrated a statistically significant benefit in recurrence-free survival

27 Oct 2022

Incyte’s phase 3 Opzelura data shows significant improvements in vitiligo trial

The positive data has been published in The New England Journal of Medicine

21 Oct 2022

Biogen doses first patient with litifilimab in cutaneous lupus erythematosus study

The phase 2/3 study is expected to be conducted at approximately 238 sites worldwide

21 Oct 2022